Search Results - "Dimery, Isaiah W."

13-cis-retinoic acid in the treatment of oral leukoplakia by Hong, W K, Endicott, J, Itri, L M, Doos, W, Batsakis, J G, Bell, R, Fofonoff, S, Byers, R, Atkinson, E N, Vaughan, C

“…13-cis-Retinoic acid has been reported to be effective in treating oral leukoplakia. We randomly assigned 44 patients with this disease to receive…”
Get more information

Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck by Hong, Waun KI, Lippman, Scott M, Itri, Loretta M, Karp, Daniel D, Lee, Jin S, Byers, Robert M, Schantz, Stimson P, Kramer, Alan M, Lotan, Reuben, Peters, Lester J, Dimery, Isaiah W, Brown, Barry W, Goepfert, Helmuth

“…Cancers of the lung, esophagus, and head and neck are expected to account for nearly one third of the 500,000 deaths due to cancer that have been predicted to…”
Get full text

Phase II Study of Irinotecan Plus Cisplatin in Patients With Advanced Non–Small-Cell Lung Cancer by DEVORE, R. F, JOHNSON, D. H, MILLER, L. L, CRAWFORD, J, GARST, J, DIMERY, I. W, ECKARDT, J, ECKHARDT, S. G, ELFRING, G. L, SCHAAF, L. J, HANOVER, C. K

“…To evaluate the antitumor efficacy and safety of a combination of irinotecan (CPT-11) and cisplatin in patients with inoperable non-small-cell lung cancer…”
Get full text

A multicenter study of the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib plus durvalumab in patients with relapsed/refractory (R/R) solid tumors by Hong, David S., Rasco, Drew W., Veeder, Michael H., Luke, Jason J., Chandler, Jason, Balmanoukian, Ani Sarkis, George, Thomas J., Munster, Pamela, Berlin, Jordan, Gutierrez, Martin, Mita, Alain C., Wakelee, Heather A., Samakoglu, Selda, Guan, Shanhong, Dimery, Isaiah W., Borazanci, Erkut

“…Abstract only…”
Get full text

Abstract B42: Ibrutinib in combination with durvalumab (MEDI4736) in patients with relapsed or refractory HER2-positive or triple-negative breast cancer: A phase 1b/2 multicenter study by Rasco, Drew W., Borazanci, Erkut, Guiterrez, Martin, Hong, David, Tawashi, Ahmed, Lin, Jennifer, Dimery, Isaiah W., Fosdale, Mark

“…Abstract Purpose: HER2+ and triple-negative (TN) breast cancers (BC) are associated with an aggressive course and poor prognosis, with currently available…”
Get full text

Ibrutinib + durvalumab (MEDI4736) in patients (pts) with relapsed or refractory (R/R) pancreatic adenocarcinoma (PAC): A phase Ib/II multicenter study by Borazanci, Erkut Hasan, Hong, David S., Gutierrez, Martin, Rasco, Drew W., Reid, Tony R., Veeder, Michael H., Tawashi, Ahmed, Lin, Jennifer, Dimery, Isaiah W.

“…Abstract only TPS484 Background: PAC is an aggressive disease characterized by poor prognosis and is inadequately treated with available therapies. Ibrutinib…”
Get full text

Superselective intra-arterial chemotherapy of advanced paranasal sinus tumors by Lee, Y Y, Dimery, I W, Van Tassel, P, De Pena, C, Blacklock, J B, Goepfert, H

“…Twenty-four patients with advanced paranasal sinus tumors were treated with combined superselective intra-arterial and systemic chemotherapy, yielding an…”
Get more information

Estrogen receptors in normal salivary gland and salivary gland carcinoma by Dimery, I W, Jones, L A, Verjan, R P, Raymond, A K, Goepfert, H, Hong, W K

“…To access for possible hormone dependence, 19 samples of normal salivary gland tissue and 14 samples of salivary gland carcinoma were quantitatively analyzed…”
Get more information

Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience by Shirinian, M H, Weber, R S, Lippman, S M, Dimery, I W, Earley, C L, Garden, A S, Michaelson, J, Morrison, W H, Kramer, A, Byers, R

“…Standard treatment of locally advanced laryngeal, hypopharyngeal, and some oropharyngeal cancers includes total laryngectomy. In an attempt to preserve the…”
Get more information

Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma by Dimery, I W, Legha, S S, Shirinian, M, Hong, W K

“…Seventeen patients with recurrent or unresectable salivary gland carcinomas were treated with combination fluorouracil (5-FU), doxorubicin, cyclophosphamide,…”
Get more information

Association of the Epstein-Barr virus with lymphoepithelioma of the thymus by Dimery, I W, Lee, J S, Blick, M, Pearson, G, Spitzer, G, Hong, W K

“…A 30-year-old woman with the histologic diagnosis of lymphoepithelioma of the thymus is reported on. Investigation of Epstein-Barr serology showed evidence of…”
Get more information

Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience by Papadimitrakopoulou, V A, Dimery, I W, Lee, J J, Perez, C, Hong, W K, Lippman, S M

“…To determine the efficacy of the combination of cisplatin, fluorouracil, and high-dose l-leucovorin (PFL) as organ-preserving induction therapy followed by…”
Get more information

A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck by HUBER, M. H, LIPPMAN, S. M, BENNER, S. E, SHIRINIAN, M, DIMERY, I. W, DUNNINGTON, J. S, WAUN KI HONG

“…Chemotherapy has not significantly altered the overall survival of patients with recurrent squamous cell carcinoma of the head and neck; therefore, the…”
Get full text

Adjuvant chemotherapy for advanced nasopharyngeal carcinoma by Dimery, I W, Legha, S S, Peters, L J, Goepfert, H, Oswald, M J

“…The outcome of therapy is reported in 34 previously untreated patients with advanced-stage (AJC IV) nasopharyngeal carcinoma treated with combination…”
Get more information

Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx by Peters, L J, Harrison, M L, Dimery, I W, Fields, R, Goepfert, H, Oswald, M J

“…Between 1975 and 1984, 33 patients with squamous cell carcinoma of the nasopharynx received adjuvant chemotherapy before and/or after definitive radiotherapy…”
Get more information

Adjuvant chemotherapy of head and neck cancer: the past, the present, and the future by Choksi, A J, Dimery, I W, Hong, W K

“…In the past two decades, overall survival of head and neck cancer patients has not improved significantly, despite improvements in surgery and radiotherapy…”
Get more information

Phase II trial of 13-cis-retinoic acid plus interferon-α in recurrent head and neck cancer by VORAVUD, N, LIPPMAN, S. M, WEBER, R. S, RODRIQUEZ, G. I, YEE, D, DIMERY, I. W, EARLEY, C. L, VON HOFF, D. D, WAUN KI HONG

“…13-cis-retinoic acid (isotretinoin) and interferon-alpha have limited activity as single agents in advanced cancer. Preclinical data indicate that these agents…”
Get full text

A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer by Vokes, E E, Dimery, I W, Jacobs, C D, Karp, D, Molina, A, Collier, M A, Eble, M L, Clendeninn, N J

“…Thirty patients with recurrent and/or metastatic head and neck cancer were treated with sequentially administered methotrexate (MTX) and piritrexim (PTX). The…”
Get more information

Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck by Dimery, I W, Brooks, B J, Winn, R, Martin, T, Shirinian, M, Hong, W K

“…Cisplatin is one of the most active chemotherapeutic agents for the treatment of squamous carcinoma of the head and neck; however, neurotoxicity and…”
Get more information

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer by Lee, J S, Libshitz, H I, Fossella, F V, Murphy, W K, Pang, A C, Lippman, S M, Shin, D M, Dimery, I W, Glisson, B S, Hong, W K

“…The authors treated 32 patients with Stage IIIB or IV non-small cell lung cancer (NSCLC) with an outpatient regimen of edatrexate…”
Get more information